Synthetic Blood International, Inc. (SYBD) to Seek Shareholder Approval for Name Change  
4/22/2008 8:49:32 AM

COSTA MESA, Calif.--(BUSINESS WIRE)--Synthetic Blood International, Inc. (OTCBB:SYBD) today announced that it will ask shareholders to approve a name change among other issues in the proxy statement that is being mailed early next week pertaining to a shareholder meeting scheduled for June 17, 2008. The new name proposed for the company is Oxygen Biotherapeutics, Inc.